Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland

[1]  A. Talei,et al.  Medullary Thyroid Carcinoma , 2000, Acta Cytologica.

[2]  G. Sterrett,et al.  Medullary carcinoma of the thyroid , 1998 .

[3]  T. Löning,et al.  Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. , 1988, American journal of clinical pathology.

[4]  W. Böcker,et al.  Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content , 1988, Cancer.

[5]  I. Ellis,et al.  Helix pomatia and Ulex Europeus lectin binding in human breast carcinoma , 1987, The Journal of pathology.

[6]  G. Reifenberger,et al.  Leu-M1 immunoreactivity in the human brain , 1987, Naturwissenschaften.

[7]  J. Mulshine,et al.  Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells. , 1986, Journal of the National Cancer Institute.

[8]  H. Battifora,et al.  Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen. , 1986, The American journal of pathology.

[9]  H. Battifora,et al.  Leu-Ml Antigen in Human Neoplasms: An Immunohistologic Study of 400 Cases , 1986, The American journal of surgical pathology.

[10]  G. Pinkus,et al.  Leu-M1 immunoreactivity in nonhematopoietic neoplasms and myeloproliferative disorders. An immunoperoxidase study of paraffin sections. , 1986, American journal of clinical pathology.

[11]  S. Hsu,et al.  L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen. , 1986, The American journal of pathology.

[12]  R. Wieczorek,et al.  Leu-M1 antigen expression in T-cell neoplasia. , 1985, The American journal of pathology.

[13]  C. Fenoglio-Preiser,et al.  Medullary carcinoma of the thyroid gland: Clinical, pathological, and immunohistochemical features with review of the literature , 1985, The American journal of surgical pathology.

[14]  K. Kakudo,et al.  Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm , 1985, Cancer.

[15]  G. Pinkus,et al.  Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. , 1985, The American journal of pathology.

[16]  K. Emmertsen.  Medullary thyroid carcinoma and calcitonin. , 1985, Danish medical bulletin.

[17]  M. Saad,et al.  Medullary Carcinoma of the Thyroid: A STUDY OF THE CLINICAL FEATURES AND PROGNOSTIC FACTORS IN 161 PATIENTS , 1984, Medicine.

[18]  E. Jaffe,et al.  Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. , 1984, American journal of clinical pathology.

[19]  B. Rasmusson.  Clinical traits in medullary carcinoma of the thyroid. , 1984, Danish medical bulletin.

[20]  B. Caillou,et al.  Medullary thyroid carcinoma: prognostic factors and treatment. , 1983, International journal of radiation oncology, biology, physics.

[21]  B. Siddiqui,et al.  Membrane-associated, fucose-containing glycoproteins and glycolipids of cultured epithelial cells from human colonic adenocarcinoma and fetal intestine. , 1982, European journal of cancer & clinical oncology.

[22]  W. Simpson,et al.  Management of medullary carcinoma of the thyroid. , 1982, American Journal of Surgery.

[23]  J. Kearney,et al.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. , 1982, Clinical immunology and immunopathology.

[24]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  B. Cady,et al.  Nonfamilial medullary thyroid carcinoma. , 1980, American journal of surgery.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  T. Löning,et al.  Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland , 2004, Virchows Archiv A.

[28]  インターグループ.  SAS user's guide : basics , 1986 .

[29]  J. Nesland,et al.  Medullary carcinoma of the thyroid gland: an immunocytochemical study. , 1985, Ultrastructural pathology.

[30]  J. Ranstam,et al.  Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years. , 1985, Acta radiologica. Oncology.

[31]  B. Spiessl,et al.  TNM-atlas : illustrated guide to the classification of malignant tumours , 1982 .

[32]  D.,et al.  Regression Models and Life-Tables , 2022 .